v3.25.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net (loss) $ (7,231,317) $ (5,662,918)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation and amortization 43,332 130,554
Share-based compensation 1,155,480 2,104,126
Debt discount for warrants 2,041,490 1,488,928
Impairment of goodwill 1,271,306 [1]
Loss on disposal of equipment 31,000 (327,608)
Prepaid expenses 81,317 4,862
Accounts payable and accrued expenses 757,317 331,748
Other liabilities 207,938
Net cash (used in) operating activities (1,642,136) (1,930,308)
Cash flows from investing activities:    
Purchase of computer equipment (50,000)
Net cash (used in) investing activities (50,000)
Cash flows from financing activities:    
Payment of notes payable (227,251) (761,671)
Proceeds from issuance of notes payable 1,806,751 2,750,646
Proceeds from common stock issuance 25,000 26,240
Net cash provided by financing activities 1,604,500 2,015,215
Net (decrease) increase in cash and cash equivalents (37,636) 34,907
Cash and cash equivalents at the beginning of the period 110,606 75,699
Cash and cash equivalents at the end of the period $ 72,970 $ 110,606
[1] Based on an annual review performed on December 31, 2023, the Company determined that its goodwill and intangible assets had been fully impaired and recorded an impairment charge amounting to $1,271,306.